Today: 19 January 2026
Subscribe

Mineralys Therapeutics (MLYS) stock slides today as biotech weakens; FDA filing timeline in focus

Mineralys Therapeutics (MLYS) stock slides today as biotech weakens; FDA filing timeline in focus

NEW YORK, December 30, 2025, 13:38 ET — Regular session Shares of Mineralys Therapeutics Inc fell 3.3% to $35.61 by early afternoon on Tuesday, after touching a session low of $35.17. About 513,000 shares had changed hands, versus a previous close of $36.83. Mineralys has a market value of about $2.9 billion and remains up about 183% over the past…
30 December 2025
····
Silver price today: SLV jumps nearly 7% as silver rebounds after record-high rout

Silver price today: SLV jumps nearly 7% as silver rebounds after record-high rout

NEW YORK, December 30, 2025, 13:30 ET — Regular session Silver prices rebounded on Tuesday after a sharp pullback from record highs, pushing the iShares Silver Trust (SLV) up about 6.9% in New York trade. Spot silver was up 4.7% at $76.38 an ounce at 11:29 a.m. ET, a day after touching an all-time high of $83.62 and suffering its…
30 December 2025
····
Gold price rebounds today as Fed minutes near; GLD and Newmont stocks climb

Gold price rebounds today as Fed minutes near; GLD and Newmont stocks climb

NEW YORK, December 30, 2025, 13:25 ET — Regular session Gold prices rebounded on Tuesday and gold-linked shares traded higher in midday U.S. dealings, as investors positioned ahead of Federal Reserve minutes due later in the session. Spot gold was around $4,373 an ounce, up about 1% on the day, according to Kitco data. Kitco The swing matters now because…
30 December 2025
····
Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

NEW YORK, December 30, 2025, 13:33 ET — Regular session Rhythm Pharmaceuticals shares were down 4.2% at $107.85 at 1:33 p.m. ET on Tuesday, after trading as low as $106.65. The move matters because Rhythm is a single-product rare-disease biotech whose stock has tended to swing on regulatory and clinical milestones for Imcivree, its obesity drug. Investors are watching the…
30 December 2025
···
S&P 500 Slips Before Fed Minutes as Meta Rises on Manus AI Deal

S&P 500 Slips Before Fed Minutes as Meta Rises on Manus AI Deal

NEW YORK, December 30, 2025, 13:22 ET — Regular session U.S. stocks edged lower in holiday-thin trade on Tuesday, with the S&P 500 and Nasdaq near flat as investors waited for the Federal Reserve’s meeting minutes. Meta Platforms rose after saying it will buy AI startup Manus, helping support communication services shares. At 12:00 p.m. ET, the Dow fell 0.24%,…
30 December 2025
···
Warby Parker stock price today: WRBY falls nearly 4% in thin year-end trading

Warby Parker stock price today: WRBY falls nearly 4% in thin year-end trading

NEW YORK, December 30, 2025, 13:34 ET — Regular session Warby Parker Inc (WRBY) shares fell about 3.9% to $22.11 in early afternoon trading on Tuesday, after ending Monday at $23.00. The stock opened at $22.90 and traded between $21.87 and $23.13, with nearly 3 million shares changing hands; the company is valued at about $3.4 billion. The slide comes…
30 December 2025
····
Vipshop stock slides about 5% today as Jefferies flags softer December trends ahead of Fed minutes

Vipshop stock slides about 5% today as Jefferies flags softer December trends ahead of Fed minutes

NEW YORK, December 30, 2025, 1:14 PM ET — Regular session Vipshop Holdings Limited (VIPS) shares fell about 5% on Tuesday, trading around $18.39 in afternoon dealings. The drop came in a muted U.S. session with year-end liquidity thin, leaving single-stock swings more pronounced than usual. Reuters Investors are also waiting for the Federal Reserve’s minutes from its Dec. 9-10…
30 December 2025
···
Corcept stock slides nearly 9% as FDA decision deadline arrives — what’s driving CORT today

Corcept stock slides nearly 9% as FDA decision deadline arrives — what’s driving CORT today

NEW YORK, December 30, 2025, 13:14 ET — Regular session Corcept Therapeutics Inc shares fell 8.9% to $72.72 in early afternoon Nasdaq trading on Tuesday, after touching a session low of $72.26. The stock was last down $7.10 from Monday’s close, with about 897,000 shares traded. The decline comes as investors focus on Corcept on the day the U.S. Food…
30 December 2025
····
D-Wave Quantum stock pops today as QBTS outperforms on year-end options buzz

D-Wave Quantum stock pops today as QBTS outperforms on year-end options buzz

NEW YORK, December 30, 2025, 1:03 PM ET — Regular session D-Wave Quantum Inc. shares climbed on Tuesday, extending a choppy year-end stretch for quantum-computing stocks as the group again outperformed a flat-to-weaker U.S. market. Reuters The move matters because quantum names have become a high-beta pocket of the tech market, with swings amplified by thin holiday liquidity and active…
30 December 2025
····
Equinox Gold stock climbs as gold rebounds — here’s what’s moving EQX today

Equinox Gold stock climbs as gold rebounds — here’s what’s moving EQX today

NEW YORK, December 30, 2025, 13:01 ET — Regular session Equinox Gold Corp shares rose about 2.2% on Tuesday, trading around $14.30, as a rebound in gold prices lifted the sector. The stock traded between $14.18 and $14.58, with about 2.2 million shares changing hands. The move matters because the gold market has turned choppy into year-end after a powerful…
30 December 2025
···
1 … 559 560 561 562 563 … 2,186

Stock Market Today

  • Sensex Drops Over 300 Points as US-EU Tariff Fears Shake Markets
    January 19, 2026, 7:43 AM EST. Indian benchmark Sensex fell over 300 points on Friday, with the Nifty sliding below the 25,600 level amid renewed global trade tensions. The sell-off followed U.S. President Donald Trump's threat of tariffs on eight European nations, sparking volatility and a flight to safe-haven assets like gold. Experts cite concerns over a US-EU trade dispute and ongoing foreign investor outflows as key factors. Technical analysis indicates continued bearish pressure on the Nifty, struggling under its 20-day exponential moving average and facing resistance near 25,700. Elevated India VIX levels point to further market fear and potential declines toward 25,200. Analysts expect volatile stock-specific moves during the earnings season while broader market consolidation appears likely as global headwinds persist.
Go toTop